Brief: Vivos Therapeutics And SoundHealth Collaborate To Expand Access To Groundbreaking FDA-Cleared Allergy And Sleep Technologies
05/02/2026 13:56
Feb 5 (Reuters) - Vivos Therapeutics Inc VVOS.O: VIVOS THERAPEUTICS AND SOUNDHEALTH ANNOUNCE COLLABORATION TO EXPAND ACCESS TO SOUNDHEALTH’S GROUNDBREAKING FDA-CLEARED ALLERGY AND SLEEP TECHNOLOGIES Source text: ID:nGNX8xLXZh Further company coverage: VVOS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth